VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

  • VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences .
  • Study protocol incorporates remote visits via VirTrial’s telehealth platform.
  • A hybrid decentralized clinical trial eliminates barriers to participation for SCI/D patients who have limited access to travel or suffer from the physical toll travel takes on them.
  • At each remote visit, a registered nurse visits the patient in their home and in conjunction with the physician, who is connected via the telehealth platform, conducts a physical exam.

Read full article: businesswire.com